• Home
  • Pharmaceuticals and Healthcare
Breast Cancer Predictive Genetic Testing Market - Global Outlook and Forecast 2022-2028

Breast Cancer Predictive Genetic Testing Market - Global Outlook and Forecast 2022-2028

Report Code: KNJ1156146 | No. of Pages: 69 | Category: Pharmaceuticals and Healthcare
Publisher: Market Monitor Global | Date of Publish: Jan-2022 
This report contains market size and forecasts of Breast Cancer Predictive Genetic Testing in Global, including the following market information:
Global Breast Cancer Predictive Genetic Testing Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Breast Cancer Predictive Genetic Testing market was valued at  million in 2021 and is projected to reach US$  million by 2028, at a CAGR of  % during the forecast period.
The U.S. Market is Estimated at $  Million in 2021, While China is Forecast to Reach $  Million by 2028.
High Penetrant Genes Segment to Reach $  Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Breast Cancer Predictive Genetic Testing include Roche, Thermo Fisher Scientific, PerkinElmer, Quest Diagnostics, Myriad Genetics, Iverson Genetics, Cancer Genetics, OncoCyte Corporation and NeoGenomics and  etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Breast Cancer Predictive Genetic Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Breast Cancer Predictive Genetic Testing Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Breast Cancer Predictive Genetic Testing Market Segment Percentages, by Type, 2021 (%)
    High Penetrant Genes
    Intermediate Penetrant Genes
    Low Penetrant Genes
Global Breast Cancer Predictive Genetic Testing Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Breast Cancer Predictive Genetic Testing Market Segment Percentages, by Application, 2021 (%)
    Hospitals
    Clinics
    Others
Global Breast Cancer Predictive Genetic Testing Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Breast Cancer Predictive Genetic Testing Market Segment Percentages, By Region and Country, 2021 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Breast Cancer Predictive Genetic Testing revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Breast Cancer Predictive Genetic Testing revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
    Roche
    Thermo Fisher Scientific
    PerkinElmer
    Quest Diagnostics
    Myriad Genetics
    Iverson Genetics
    Cancer Genetics
    OncoCyte Corporation
    NeoGenomics
    Invitae
1 Introduction to Research & Analysis Reports
    1.1 Breast Cancer Predictive Genetic Testing Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Breast Cancer Predictive Genetic Testing Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Breast Cancer Predictive Genetic Testing Overall Market Size
    2.1 Global Breast Cancer Predictive Genetic Testing Market Size: 2021 VS 2028
    2.2 Global Breast Cancer Predictive Genetic Testing Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Breast Cancer Predictive Genetic Testing Players in Global Market
    3.2 Top Global Breast Cancer Predictive Genetic Testing Companies Ranked by Revenue
    3.3 Global Breast Cancer Predictive Genetic Testing Revenue by Companies
    3.4 Top 3 and Top 5 Breast Cancer Predictive Genetic Testing Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Breast Cancer Predictive Genetic Testing Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Breast Cancer Predictive Genetic Testing Players in Global Market
        3.6.1 List of Global Tier 1 Breast Cancer Predictive Genetic Testing Companies
        3.6.2 List of Global Tier 2 and Tier 3 Breast Cancer Predictive Genetic Testing Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Breast Cancer Predictive Genetic Testing Market Size Markets, 2021 & 2028
        4.1.2 High Penetrant Genes
        4.1.3 Intermediate Penetrant Genes
        4.1.4 Low Penetrant Genes
    4.2 By Type - Global Breast Cancer Predictive Genetic Testing Revenue & Forecasts
        4.2.1 By Type - Global Breast Cancer Predictive Genetic Testing Revenue, 2017-2022
        4.2.2 By Type - Global Breast Cancer Predictive Genetic Testing Revenue, 2023-2028
        4.2.3 By Type - Global Breast Cancer Predictive Genetic Testing Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Breast Cancer Predictive Genetic Testing Market Size, 2021 & 2028
        5.1.2 Hospitals
        5.1.3 Clinics
        5.1.4 Others
    5.2 By Application - Global Breast Cancer Predictive Genetic Testing Revenue & Forecasts
        5.2.1 By Application - Global Breast Cancer Predictive Genetic Testing Revenue, 2017-2022
        5.2.2 By Application - Global Breast Cancer Predictive Genetic Testing Revenue, 2023-2028
        5.2.3 By Application - Global Breast Cancer Predictive Genetic Testing Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Breast Cancer Predictive Genetic Testing Market Size, 2021 & 2028
    6.2 By Region - Global Breast Cancer Predictive Genetic Testing Revenue & Forecasts
        6.2.1 By Region - Global Breast Cancer Predictive Genetic Testing Revenue, 2017-2022
        6.2.2 By Region - Global Breast Cancer Predictive Genetic Testing Revenue, 2023-2028
        6.2.3 By Region - Global Breast Cancer Predictive Genetic Testing Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Breast Cancer Predictive Genetic Testing Revenue, 2017-2028
        6.3.2 US Breast Cancer Predictive Genetic Testing Market Size, 2017-2028
        6.3.3 Canada Breast Cancer Predictive Genetic Testing Market Size, 2017-2028
        6.3.4 Mexico Breast Cancer Predictive Genetic Testing Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Breast Cancer Predictive Genetic Testing Revenue, 2017-2028
        6.4.2 Germany Breast Cancer Predictive Genetic Testing Market Size, 2017-2028
        6.4.3 France Breast Cancer Predictive Genetic Testing Market Size, 2017-2028
        6.4.4 U.K. Breast Cancer Predictive Genetic Testing Market Size, 2017-2028
        6.4.5 Italy Breast Cancer Predictive Genetic Testing Market Size, 2017-2028
        6.4.6 Russia Breast Cancer Predictive Genetic Testing Market Size, 2017-2028
        6.4.7 Nordic Countries Breast Cancer Predictive Genetic Testing Market Size, 2017-2028
        6.4.8 Benelux Breast Cancer Predictive Genetic Testing Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Breast Cancer Predictive Genetic Testing Revenue, 2017-2028
        6.5.2 China Breast Cancer Predictive Genetic Testing Market Size, 2017-2028
        6.5.3 Japan Breast Cancer Predictive Genetic Testing Market Size, 2017-2028
        6.5.4 South Korea Breast Cancer Predictive Genetic Testing Market Size, 2017-2028
        6.5.5 Southeast Asia Breast Cancer Predictive Genetic Testing Market Size, 2017-2028
        6.5.6 India Breast Cancer Predictive Genetic Testing Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Breast Cancer Predictive Genetic Testing Revenue, 2017-2028
        6.6.2 Brazil Breast Cancer Predictive Genetic Testing Market Size, 2017-2028
        6.6.3 Argentina Breast Cancer Predictive Genetic Testing Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Breast Cancer Predictive Genetic Testing Revenue, 2017-2028
        6.7.2 Turkey Breast Cancer Predictive Genetic Testing Market Size, 2017-2028
        6.7.3 Israel Breast Cancer Predictive Genetic Testing Market Size, 2017-2028
        6.7.4 Saudi Arabia Breast Cancer Predictive Genetic Testing Market Size, 2017-2028
        6.7.5 UAE Breast Cancer Predictive Genetic Testing Market Size, 2017-2028
7 Players Profiles
    7.1 Roche
        7.1.1 Roche Corporate Summary
        7.1.2 Roche Business Overview
        7.1.3 Roche Breast Cancer Predictive Genetic Testing Major Product Offerings
        7.1.4 Roche Breast Cancer Predictive Genetic Testing Revenue in Global Market (2017-2022)
        7.1.5 Roche Key News
    7.2 Thermo Fisher Scientific
        7.2.1 Thermo Fisher Scientific Corporate Summary
        7.2.2 Thermo Fisher Scientific Business Overview
        7.2.3 Thermo Fisher Scientific Breast Cancer Predictive Genetic Testing Major Product Offerings
        7.2.4 Thermo Fisher Scientific Breast Cancer Predictive Genetic Testing Revenue in Global Market (2017-2022)
        7.2.5 Thermo Fisher Scientific Key News
    7.3 PerkinElmer
        7.3.1 PerkinElmer Corporate Summary
        7.3.2 PerkinElmer Business Overview
        7.3.3 PerkinElmer Breast Cancer Predictive Genetic Testing Major Product Offerings
        7.3.4 PerkinElmer Breast Cancer Predictive Genetic Testing Revenue in Global Market (2017-2022)
        7.3.5 PerkinElmer Key News
    7.4 Quest Diagnostics
        7.4.1 Quest Diagnostics Corporate Summary
        7.4.2 Quest Diagnostics Business Overview
        7.4.3 Quest Diagnostics Breast Cancer Predictive Genetic Testing Major Product Offerings
        7.4.4 Quest Diagnostics Breast Cancer Predictive Genetic Testing Revenue in Global Market (2017-2022)
        7.4.5 Quest Diagnostics Key News
    7.5 Myriad Genetics
        7.5.1 Myriad Genetics Corporate Summary
        7.5.2 Myriad Genetics Business Overview
        7.5.3 Myriad Genetics Breast Cancer Predictive Genetic Testing Major Product Offerings
        7.5.4 Myriad Genetics Breast Cancer Predictive Genetic Testing Revenue in Global Market (2017-2022)
        7.5.5 Myriad Genetics Key News
    7.6 Iverson Genetics
        7.6.1 Iverson Genetics Corporate Summary
        7.6.2 Iverson Genetics Business Overview
        7.6.3 Iverson Genetics Breast Cancer Predictive Genetic Testing Major Product Offerings
        7.6.4 Iverson Genetics Breast Cancer Predictive Genetic Testing Revenue in Global Market (2017-2022)
        7.6.5 Iverson Genetics Key News
    7.7 Cancer Genetics
        7.7.1 Cancer Genetics Corporate Summary
        7.7.2 Cancer Genetics Business Overview
        7.7.3 Cancer Genetics Breast Cancer Predictive Genetic Testing Major Product Offerings
        7.7.4 Cancer Genetics Breast Cancer Predictive Genetic Testing Revenue in Global Market (2017-2022)
        7.7.5 Cancer Genetics Key News
    7.8 OncoCyte Corporation
        7.8.1 OncoCyte Corporation Corporate Summary
        7.8.2 OncoCyte Corporation Business Overview
        7.8.3 OncoCyte Corporation Breast Cancer Predictive Genetic Testing Major Product Offerings
        7.8.4 OncoCyte Corporation Breast Cancer Predictive Genetic Testing Revenue in Global Market (2017-2022)
        7.8.5 OncoCyte Corporation Key News
    7.9 NeoGenomics
        7.9.1 NeoGenomics Corporate Summary
        7.9.2 NeoGenomics Business Overview
        7.9.3 NeoGenomics Breast Cancer Predictive Genetic Testing Major Product Offerings
        7.9.4 NeoGenomics Breast Cancer Predictive Genetic Testing Revenue in Global Market (2017-2022)
        7.9.5 NeoGenomics Key News
    7.10 Invitae
        7.10.1 Invitae Corporate Summary
        7.10.2 Invitae Business Overview
        7.10.3 Invitae Breast Cancer Predictive Genetic Testing Major Product Offerings
        7.10.4 Invitae Breast Cancer Predictive Genetic Testing Revenue in Global Market (2017-2022)
        7.10.5 Invitae Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

NEED Help?

If you need any help or guidance, please feel free to call us.

USA : +1 (661) 636 6162

INDIA : +91 9325802062

or

Write us on : sales@kandjmarketresearch.com